IMS Health to Announce First-Quarter 2016 Results on May 4, 2016
Get Alerts IMS Hot Sheet
Join SI Premium – FREE
DANBURY, Conn.--(BUSINESS WIRE)-- IMS Health Holdings, Inc. (“IMS Health”) (NYSE: IMS) will issue its first-quarter 2016 financial results before the market opens on Wednesday, May 4, 2016. The earnings release and accompanying financial information will be posted on the IMS Health Investor Relations website at http://ir.imshealth.com.
IMS Health’s management team will host a conference call and webcast to discuss the company’s results at 9:00 a.m. Eastern Time on May 4. Interested parties are invited to listen to the live event and view the presentation slides via webcast on IMS Health’s Investor Relations website at http://ir.imshealth.com. The discussion also will be available by dialing +1-800-920-2986 in the U.S. and Canada, or +1-212-231-2915 for international callers.
A replay of the webcast will be available approximately two hours after the conclusion of the live event on May 4. To access the webcast recording, visit http://ir.imshealth.com.
About IMS Health
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,000 services experts connect configurable SaaS applications to 15+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at www.imshealth.com.
IMSFIN
View source version on businesswire.com: http://www.businesswire.com/news/home/20160420006109/en/
IMS Health
Investor Relations
Tom Kinsley, +1-203-448-4691
[email protected]
or
Media
Relations
Tor Constantino, +1-484-567-6732
[email protected]
Source: IMS Health
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Range Resources (RRC) PT Raised to $41 at Mizuho
- NOV Inc (NOV) Tops Q1 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!